Skip to main content
. 2006 Nov 14;95(11):1598–1602. doi: 10.1038/sj.bjc.6603472

Figure 2.

Figure 2

Comparison of percent distribution of CD4+ counts at NHL diagnosis (A) and NHL subtype (B) between 100 anti-HCV+ and 198 anti-HCV NHL cases. Swiss HIV Cohort Study, 1984–2004. Anti-HCV: antibodies against hepatitis C virus; PBL: Primary brain lymphoma; DLBC: diffuse large B-cell NHL. ‘Unknown’ refers to no CD4+ count result within 6 months before cancer diagnosis.